Immunohistochemical Characterization of Facioscapulohumeral Muscular Dystrophy Muscle Biopsies

Jeffrey M Statland1, Karen J Odrzywolski2, Bharati Shah2

  • 1Department of Neurology, University of Kansas Medical Center, Kansas City, KS ; Department of Neurology, University of Rochester Medical Center, Rochester, NY.

Abstract

Insights

Facioscapulohumeral muscular dystrophy (FSHD) shows increased apoptosis and reduced capillary density in muscle tissue. These findings suggest potential histopathological markers of disease activity in FSHD patients.

Area of Science:

  • Muscle pathology
  • Neuromuscular disorders
  • Genetics

Background:

  • Facioscapulohumeral muscular dystrophy (FSHD) pathogenesis may involve gene activation, oxidative stress, and apoptosis.
  • Understanding these mechanisms is crucial for developing targeted therapies.

Purpose of the Study:

  • To investigate histopathological changes in FSHD muscle biopsies.
  • To correlate observed changes with proposed disease mechanisms.

Main Methods:

  • Cross-sectional study of quadriceps muscle biopsies from 32 FSHD participants.
  • Comparison with healthy volunteers and myotonic dystrophy type 1 controls.
  • Evaluation of apoptosis rates, capillary density, myonuclear, and satellite cell counts.

Main Results:

  • Increased apoptosis rates in FSHD (0.74%) versus controls (0.13-0.14%, P<0.003).
  • Apoptosis correlated with smaller D4Z4 fragment sizes in FSHD.
  • Decreased capillary density in FSHD (316/mm²) compared to healthy controls (448/mm², P=0.001).
  • No significant differences in myonuclear or satellite cell counts.

Conclusions:

  • Elevated apoptosis and reduced capillary density in FSHD muscle biopsies suggest histopathological correlates of disease activity.
  • Further research is needed to elucidate the molecular underpinnings of these observed changes.